PYRROLOBENZODIAZEPINKONJUGATE

European patent · EP3413923 · In force

Register entry

Publication number
EP3413923
Application number
EP17704263
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Feb 10, 2017
Published
Dec 19, 2018
Granted
Apr 8, 2020
Protection ends at the latest
Feb 9, 2037
Next annual fee due
Feb 28, 2027
IPC classes
A61K 47/68 (2017.01)
A61P 35/00 (2006.01)
Priority
GB 201602356 10.02.2016
PCT application
PCT/EP2017/052988 10.02.2017
PCT publication
WO2017/137553 17.08.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Mar 1, 2026

    Change

    Published in Swissreg on 01.03.2026

  2. Mar 1, 2025

    Change

    Published in Swissreg on 01.03.2025

  3. Mar 1, 2024

    Change

    Published in Swissreg on 01.03.2024

  4. Mar 6, 2023

    Change

    Published in Swissreg on 06.03.2023

  5. Apr 8, 2020

    Granted

    Published in Swissreg on 08.04.2020

Parties

Holder

Medimmune Limited

Milstein Building Granta Park, Cambridge, Cambridgeshire CB21 6GH, GB

Inventor

DUNNY, Elizabeth

Cambridge Cambridgeshire CB21 6GH, GB

MASTERSON, Luke

Cambridge Cambridgeshire CB21 6GH, GB

HOWARD, Philip Wilson

Cambridge Cambridgeshire CB21 6GH, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.